<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0942-6331-02
</NDCCode>
<PackageDescription>
49 mL in 1 BAG (0942-6331-02)
</PackageDescription>
<NDC11Code>
00942-6331-02
</NDC11Code>
<ProductNDC>
0942-6331
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Cpda-1
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Anticoagulant Citrate Phosphate Dextrose Adenine
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20100525
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
BN770420
</ApplicationNumber>
<LabelerName>
Fenwal, Inc.
</LabelerName>
<SubstanceName>
DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ADENINE
</SubstanceName>
<StrengthNumber>
1.56; 1.29; 160; 109; 13.5
</StrengthNumber>
<StrengthUnit>
g/49mL; g/49mL; mg/49mL; mg/49mL; mg/49mL
</StrengthUnit>
<Pharm_Classes>
Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-04-02
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20181231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>